Originally published at www.seclive.com
Berkshire Hathaway (BRK-A) increased its stake in DaVita HealthCare Partners (NYSE:DVA) by 4.3%, purchasing 639,200 shares for a price of $73.4M, resulting in a new total of 15.6 million shares of the dialysis provider company. DaVita recently announced that Garry Menzel will become the company's next chief financial officer, effective once the company files its form 10-Q for quarter ending September 30th. Menzel will join the company in September and assume the title of Senior Vice President, Finance until the day after the soon-due form 10-Q filing is complete. Currently, Jim Hilger has served as interim chief financial officer and will assume the position of chief accounting officer once Menzel officially takes the job. DaVita HealthCare CEO Kent Thiry remarked that the company is ready and excited to have Menzel join.
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.